Skip to main content

Table 2.

Copy. Abbreviations: GBM = glioblastoma multiforme; EGFR = epidermal growth factor receptor; FISH = fluorescence in situ hybridization; M = male; N/A = not applicable; Ch. = chromosome; BCNU = carmustine; 7cen = 7 centromere; LOH = loss of heterozygosity; PCV = procarbazine, lomustine, and vincristine; F = female; LTF = lost to follow‐up; PNET = primitive neuroectodermal tumor; F = female; C = consultation case.

Patient age, gender, race, year(s) of neurosurgical procedure Relevant history; primary, secondary or radiation‐induced GBM Tumor location/
Surgical procedure Histological features/
Extent of necrosis EGFR amplification status, as assessed by FISH TP53; MIB‐1 immunostaining, % positive nuclei Clinical outcome/
Survival
1. 18 M
Hispanic
1997 C Primary GBM Brainstem
Biopsy Fibrillary and pleomorphic
1+ N/A N/A N/A
LTF
2. 24 M
Caucasian
1997 C
1997 (2 surgical procedures same year) Primary GBM
Presented with cerebral hemorrhage, thought to have metastasis Right temporal
Biopsy
Resection
(well‐circumscribed) Epithelioid
3+ Negative for EGFR amplification
Polysomy for Ch. 7 (3–6 copies in 62.8% of cells) 2+ TP53
29.6%
MIB‐1 Developed cerebrospinal fluid dissemination (+CSF cytology)
Died
25 weeks
3. 26 M
Caucasian
1997
1997 (two outside procedures; slides unavailable for review)
1998 (GBM) Secondary GBM
Grade II oligodendroglioma 1997; radiation therapy; recurrence 1997, resection with BCNU wafers; secondary GBM 1998 Right parietal
Resection Resection Resection Fibrillary with focal small cell and pleomorphic giant cell component
2+ Negative for EGFR amplification
Polysomy for Ch. 7, 1, 19 (3–4 copies 7cen in 56.6% of cells)
Negative for LOH 1p, 19q 4+ TP53
21.8%
MIB‐1 Alive as of 2/4/1998
2 weeks
LTF
4. 27 M
Caucasian
1988 (slides reviewed)
1996
1998 (GBM) Secondary GBM
Grade II astrocytoma 1987; radiation therapy; recurrence 1996, resection with BCNU wafers, PCV; secondary GBM 1998 Left fronto‐parietal
Stereotactic biopsy
Resection
Resection Small cell
2+ Negative for EGFR amplification
Polysomy for Ch. 7, 1, 19 (3–4 copies 7cen in 40.8% of cells)
Negative for LOH 1p, 19q 4+ TP53
23.3%
MIB‐1 Developed left neck lymph node metastases
Died
48 weeks
5. 30 M
Race not specified
1998 C Primary GBM
Presented with hematoma, thought to have vascular lesion Occipital
Biopsy Fibrillary
3+ N/A N/A Died
57 weeks
6. 29 M
Race not specified
1997 C
1998 Primary GBM Right frontal lobe Fibrillary with gemistocytic and pleomorphic giant cells
1997 2+
1998 0 N/A 1+ TP53
19.3%
MIB‐1 Died
85 weeks
7. 18 M
Hispanic
1999 Primary GBM Right frontal
Resection Rhabdoid
3+
 Negative for EGFR amplification
Polysomy for Ch. 7 (3–4 copies in 19.2% of cells) 1+ TP53
26.3%
MIB‐1 Died
22 weeks
Autopsy showed residual tumor in right frontal lobe, adjacent leptomeninges
Implantation metastasis in right fronto‐parietal scalp, microscopic metastases in both lungs
8. 32 M
Caucasian
1998
1999 (GBM)
2000 (GBM) Secondary GBM
Anaplastic mixed oligoastrocytoma, 1998
GBM, 1999 Right temporal lobe
Resection
Resection Fibrillary
2+ Negative for EGFR amplification
Polysomy for Ch. 7 (3–4 copies in 64.2% of cells)
Negative for LOH 1p, Positive for LOH 19q 1+ TP53
8.2%
MIB‐1 Died
90 weeks
9. 21 M
Race not specified
2000 C Secondary GBM
Myoclonic seizures for 2 years preceding tumor discovery; neuroimaging showed lesion of left motor strip but thought to be cortical dysplasia and not biopsied. Seizures resolved, medications discontinued, pt. OK until rapid development of right hemiparesis one month before biopsy Left fronto‐parietal
Stereotactic biopsy Fibrillary with scattered multinucleated giant cells
1+ Positive high level EGFR amplification (10 to >20 copies per cell in 19.5% of cells, Ratio = 2.7)
Negative for polysomy of Ch. 7 1+ TP53
28.9%
MIB‐1 Died
42 weeks
10. 31 F
Korean
1999 (not reviewed) (GBM)
2000 (GBM + abscess)
2000 C (GBM) Primary GBM Right parieto‐occipital
Resection Fibrillary
Necrotic abscess on first surgery of 2000, positive for actinomyces N/A 4+ TP53
2.2%
MIB‐1 Alive as of 8/18/2005
297 weeks
11. 29 M
Race not specified
2000 C Primary GBM Thalamus
(side not specified)
Biopsy Fibrillary
0 N/A N/A Died
25 weeks
12. 35 M
Irish National
1998
1999
2000 (all surgeries in Ireland, slides unavailable for review)
2000 (GBM) Secondary GBM
Oligoastrocytoma 1998; recurred in 1999; received radiation therapy and temozolomide, underwent reoperation in 2000 but tumor could not be resected. Came to USA for surgery the next month Left frontal
Resection Small cell
3+ Positive for high level EGFR amplification (Ratio = 6.6)
Polysomy for Ch. 1, 7, 19 (3–4 copies 7cen in 47.7% of cells)
Negative for LOH 1p, 19q
 1+ TP53
31.6%
MIB‐1 Alive as of 12/31/2005
295 weeks
13. 27 F
Caucasian
2001
 Primary GBM
Sharply demarcated but deep in the white matter Left occipital
Resection Epithelioid
2+ Positive for cells with EGFR amplification (Ratio = 2.0, 6–20 copies in 44.1% of cells)
Polysomy for Ch. 7 (3–10 copies in 39.8% of cells) 4+ TP53
42.2%
MIB‐1 Alive as of 12/31/2005
234 weeks
14. 24 F
Caucasian
2001 C
2001 C Primary GBM Right frontal
Stereotactic biopsy
Resection N/A N/A N/A Died
122 weeks
15. 32 F
Hispanic
2001
 Probable secondary GBM
History of seizures for 6 years; symptoms had worsened recently and had delivered baby 3 months prior to surgery Right frontal lobe
Biopsy Gemistocytic
2+ N/A N/A Alive as of 3/8/2002 but LTF
28 weeks
16. 30 M
Caucasian
2001
 Secondary GBM Right occipital
Resection Fibrillary
1+ Positive for EGFR amplification
Polysomy for Ch. 7 (3 copies) N/A Alive as of 12/6/2004 but LTF
175 weeks
17. 21 M
Race not specified
2002
 Primary GBM
Presented with thalamic hemorrhage Right thalamus
Stereotactic biopsy Fibrillary
3+ Negative for EGFR amplification
Polysomy for Ch. 7 (3–4 copies in 55.7% of cells) 3+ TP53
25.6%
MIB‐1 Died
5 weeks
18. 24 M
Race not specified
2002 C Primary GBM Right frontal Fibrillary
3+ N/A N/A LTF
19. 22 M
Caucasian
1984 (ependymoma)
2002 (GBM)
2002 (GBM)
 Radiation‐induced GBM
Original tumor posterior fossa ependymoma, WHO grade II 1984 (slides reviewed) Left cerebellum
Resection
Resection Fibrillary, with prominent mucinous degeneration, profuse microvascular proliferation
0 Negative for EGFR amplification
Polysomy for Ch. 7 (4–10 copies in 49.2% of cells) 1+ TP53
10.6%
MIB‐1
 Alive as of 12/31/2005
174 weeks
20. 18 M
2002 C Race not specified Primary GBM
Germline short arm chromosome 22 abnormality, lower limb amputation for developmental anomaly, recurrent Burkitt lymphoma of gastrointestinal tract Right fronto‐parietal
Resection Epithelioid admixed with pleomorphic cells
1+ Negative for EGFR amplification
Polysomy for Ch. 7 (3–4 copies in 30.3% of cells) 4+ TP53
19.1%
MIB‐1 Alive as of 12/31/2005
173 weeks
2 years out from stem cell rescue has no residual brain tumor, receives IV/IgG for low immunoglobulin levels
21. 27 M
Hispanic
2002 Radiation‐induced GBM
Acute lymphoblastic leukemia 5 years previous Cerebellum
Biopsy Fibrillary
3+ Negative for EGFR amplification
Negative for polysomy of Ch. 7 1+ TP53
46.8%
MIB‐1 Died
47 weeks
22. 24 F
Caucasian
2002 C Primary GBM
Turcot syndrome
Poorly differentiated colon carcinoma 2002, metastatic to liver Right temporal parietal N/A N/A N/A Died
165 weeks
23. 31 M
Hispanic
2002 Primary GBM Left frontal parietal Fibrillary and small cell
3+ N/A N/A Alive as of 6/7/2002 but LTF
3 weeks
24. 34 M
Hispanic
2001 C (grade II astrocytoma)
2002 (GBM)
 Secondary GBM
Astrocytoma grade II left frontal lobe 2001 (slides reviewed); recurred as bifrontal GBM 2002 Bifrontal
Resection Small cell with scattered pleomorphic giant cells
2+ N/A 4+ TP53
46.3%
MIB‐1 Alive as of 3/4/2004 but LTF
31 weeks
25. 22 F
Race not specified
2003 C Primary GBM (gliosarcoma) Right temporal
Resection Gliosarcoma
3+ Negative for EGFR amplification
Polysomy for Ch. 7 (3 copies in 42.5% of cells) 1+ TP53
25.9%
MIB‐1 Died
34 weeks
26. 30 M
Hispanic
2003
 Primary GBM Left frontal
Resection Small cell and focal epithelioid
3+ High level of EGFR amplification (Ratio = 7.1)
Polysomy for Ch. 7 (3–4 copies in 47.6% of cells) 4+ TP53
53.8%
MIB‐1 Died
3 weeks
27. 29 M
American Indian
2003 Primary GBM Left temporal
Stereotactic biopsy Small cell
0 Negative for EGFR amplification
Polysomy for Ch. 1, 7, 19 (3–4 copies 7cen in 50.8% of cells)
No LOH 1p, 19q 1+ TP53
42.0%
MIB‐1 Died
67 weeks
28. 31 M
Caucasian
2003
2003 Primary GBM Right frontal
Stereotactic biopsy
Resection Small cell with scattered pleomorphic giant cells
2+ EGFR not performed
Negative for deletion of 1p, Positive for deletion of 19q 4+ TP53
24.5%
MIB‐1 Alive as of 12/31/2005
117 weeks
29. 25 F
Race not specified
2003 C Primary GBM
Thought to be a brain abscess Left parietal
Biopsy Fibrillary
3+ Positive for EGFR amplification (20 copies in 85% of cells) 1+ TP53
54.3%
MIB‐1 Died
61 weeks
30. 28 F
Caucasian
2004
2004 Primary GBM Right temporal
Resection
Resection Small cell
2+
 Negative for EGFR amplification
Polysomy for Ch. 7 (3–4 copies in 37.6% of cells) 1+ TP53
37.6%
MIB‐1 Died
61 weeks
31. 31 M
Caucasian
2004
 Primary GBM Left medulla
Biopsy Fibrillary and small cell
3+ Negative for EGFR amplification
Polysomy for Ch. 7 (3–4 copies in 26.8% of cells) 2+ TP53
28.9%
MIB‐1 Died
48 weeks
32. 26 M
Race not specified
2004 C Primary GBM
Presented with cerebral hemorrhage Right frontal
Resection Fibrillary and small cell
2+ Negative for EGFR amplification
Polysomy for Ch. 7 (3–4 copies in 54.2% of cells) Negative for LOH 1p, 19q 1+ TP53
21.4%
MIB‐1 Died
53 weeks
33. 29 M
Caucasian
2004
 Primary GBM Thoracic cord, T7‐T11
Resection Fibrillary and small cell
0 Negative for EGFR amplification
Negative for polysomy of Ch. 7 1+ TP53
29.8%
MIB‐1 Alive as of 12/31/2005
63 weeks
34. 34 F
Caucasian
2004 C Primary GBM Left temporal parietal Fibrillary and gemistocytic
1+ N/A N/A Died
91 weeks

35. 29 M
Race not specified
2005 C Primary GBM Right fronto‐parietal
Biopsy Small cell with unusual eosinophilic filamentous inclusions
0 Negative for EGFR amplification
Polysomy for Ch. 7 (3–4 copies in 42.5% of cells) 4+ TP53
31.7%
MIB‐1 Died
49 weeks
36. 17 M
Caucasian
2005
 Primary GBM
Presented with cerebral hemorrhage Left temporal
Resection Small cell
3+ Positive for cells with EGFR amplification (8.4% of cells, Ratio = 1.4)
Polysomy for Ch. 1, 7, 19 (3–6 copies of 7cen in 63.4% of cells)
Negative for LOH 1p, 19q 4+ TP53
69.3%
MIB‐1 Alive as of 12/31/2005
39 weeks (patient treated on PNET chemotherapy regimen)
37. 29 F
Caucasian
2005
 Primary GBM
 Left frontal
Resection Fibrillary
1+ Negative for EGFR amplification
Polysomy for Ch. 1, 7, 19 (3–4 copies 7cen in 44.2% of cells)
Negative for LOH 1p, 19q 3+ TP53
28.8%
MIB‐1 Alive as of 12/31/2005
23 weeks

38. 34 M
Caucasian
2005
 Primary GBM
Cystic mass thought to be abscess, or less likely tumor Left frontal Small cell
2+ Negative for EGFR amplification
Polysomy for Ch. 1, 7, 19 (3–6 copies 7cen in 76.8% of cells)
Negative for LOH 1p, 19q 1+ TP53
52.8%
MIB‐1 Alive as of 12/31/2005
3 weeks